Jardine Lloyd Thompson Group plc (“JLT”), one of the world’s leading providers of insurance, reinsurance and employee benefits-related advice, brokerage and associated services, is to appoint Charlie Rozes as Group Finance Director, succeeding Mike Reynolds. JLT announced in August 2014 that Mike had been appointed Chief Executive Officer of JLT Re, but would retain his position as Group Finance Director until the appointment of his successor. |
Charlie will join JLT on 1st September 2015 and, subject to Financial Conduct Authority approval, will be appointed Group Finance Director, reporting to Group Chief Executive Dominic Burke. Charlie will join the Board as an Executive Director and will also be a member of the Group Executive Committee. Mike will step down from the Board on that date, but will remain a member of the Group Executive Committee.
Charlie joins JLT from Barclays, where, since 2011, he has held the role of Global Head of Investor Relations. Prior to that, he was Chief Financial Officer of Barclays UK Retail and Business Banking. Charlie has also held senior roles at Bank of America, IBM and PricewaterhouseCoopers.
Commenting on Charlie’s appointment, Dominic Burke, Group Chief Executive of JLT, said:
“I am delighted to welcome Charlie to JLT. He is a highly-regarded and extremely accomplished finance professional whose extensive experience in the financial services sector will be of immense value to JLT. Charlie will play a pivotal role in the next stage of JLT’s growth and I very much look forward to working with him.
“I would like to thank Mike for the excellent contribution he made as Group Finance Director, in particular, the instrumental role he played in the acquisition of Towers Watson Re in 2013. I have tremendous confidence in his ability to lead JLT Re and know that he will continue to take this important business from strength to strength.”
Charlie Rozes said:
“I am delighted to be joining JLT at such an exciting time in their development. The business has transformed itself in recent years and has become a true global Specialty powerhouse. I look forward to working with Dominic and the rest of JLT’s leadership to drive the next phase in JLT’s growth.”
There are no other details that are required to be disclosed in respect of Charlie Rozes’ appointment under LR 9.6.13(R) of the FCA Listing Rules.
|
|
|
|
Pensions Data Science Actuary | ||
Offices UK wide, hybrid working - Negotiable |
Head of Pricing | ||
London - Negotiable |
Global Specialty Pricing Actuary | ||
London - £95,000 Per Annum |
Client-facing DC investment manager | ||
London / hybrid 3 dpw office-based - Negotiable |
Financial Risk Leader - Bermuda | ||
Bermuda - Negotiable |
Aylesbury Actuaries | ||
Aylesbury / hybrid 3dpw office-based - Negotiable |
Make an impact in protection pricing ... | ||
London / hybrid 2 days p/w office-based - Negotiable |
BPA Implementation Manager | ||
North / hybrid 50/50 - Negotiable |
Head of Reserving | ||
London - £160,000 Per Annum |
In-force Longevity Actuarial Analyst | ||
London / hybrid 2 dpw office-based - Negotiable |
Make a difference within reinsurance ... | ||
London / hybrid 2 dpw office-based - Negotiable |
Be at the cutting-edge of life & heal... | ||
London / hybrid 2 dpw office-based - Negotiable |
Longevity Pricing Analyst | ||
London / hybrid 2 dpw office-based - Negotiable |
Develop your career in life reinsuran... | ||
London / hybrid 2 dpw office-based - Negotiable |
Protection Pricing Actuary - Life Rei... | ||
London / hybrid 2 dpw office-based - Negotiable |
Life (Re)insurance Pricing Manager (P... | ||
London / hybrid 2 dpw office-based - Negotiable |
Take the lead: life & health reinsura... | ||
London / hybrid 2 dpw office-based - Negotiable |
Pricing Tools and Systems Developer | ||
London / hybrid 2 dpw office-based - Negotiable |
Longevity Pricing Actuary | ||
London / hybrid 2 dpw office-based - Negotiable |
Shape the future of longevity | ||
London / hybrid 2 dpw office-based - Negotiable |
Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.